Search Results - "Filetti M"

Artificial intelligence in oncology publishing: a systematic review and policy analysis of high-impact journals.

Authors: Giusti R Filetti M Lombardi P et al.

Source: Frontiers in oncology [Front Oncol] 2026 Apr 01; Vol. 16, pp. 1717048. Date of Electronic Publication: 2026 Apr 01 (Print Publication: 2026).

Publication Type: Journal Article; Systematic Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Current landscape of T-cell engagers in early-phase clinical development in solid cancers.

Authors: Spinazzola A Iannantuono GM Gulley JL et al.

Source: Frontiers in immunology [Front Immunol] 2025 Oct 06; Vol. 16, pp. 1665838. Date of Electronic Publication: 2025 Oct 06 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009-2023).

Authors: Iannantuono GM Floudas CS Filetti M et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Jul 25; Vol. 225, pp. 115589. Date of Electronic Publication: 2025 Jun 26.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Molecular mechanisms of sexual dimorphism in cancer through improved miRNA regulation-level network-based approach: MIRROR2.

Authors: Alfano C Filetti M Farina L et al.

Source: Computers in biology and medicine [Comput Biol Med] 2025 Sep; Vol. 195, pp. 110671. Date of Electronic Publication: 2025 Jun 26.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 1250250 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0534 (Electronic) Linking ISSN: 00104825 NLM ISO Abbreviation: Comput Biol Med Subsets: MEDLINE

Integration of translational research in phase III trials: A systematic review of breast cancer studies in a 5-year period.

Authors: Giannone G Lombardi P Filetti M et al.

Source: Breast (Edinburgh, Scotland) [Breast] 2025 Jun; Vol. 81, pp. 104431. Date of Electronic Publication: 2025 Mar 06.

Publication Type: Journal Article; Systematic Review

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE

An international survey on the knowledge, attitudes and clinical patterns of use of medical cannabis for cancer care: The TASMAN study.

Authors: Trapani D Nidhamalddin SJ Gandini S et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Jan 17; Vol. 215, pp. 115158. Date of Electronic Publication: 2024 Nov 30.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study.

Authors: Fletcher K Cortellini A Ganta T et al.

Source: Cancer letters [Cancer Lett] 2024 Aug 01; Vol. 596, pp. 217001. Date of Electronic Publication: 2024 Jun 03.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE

Efficacy and safety of antiemetic regimens for highly emetogenic chemotherapy-induced nausea and vomiting: A systematic review and network meta-analysis.

Authors: Filetti M Lombardi P Giusti R et al.

Source: Cancer treatment reviews [Cancer Treat Rev] 2023 Apr; Vol. 115, pp. 102512. Date of Electronic Publication: 2023 Jan 21.

Publication Type: Journal Article; Systematic Review; Network Meta-Analysis

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer.

Authors: Pinato DJ Ferrante D Aguilar-Company J et al.

Corporate Authors: Pinato DJ Ferrante D Aguilar-Company J et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Aug; Vol. 171, pp. 64-74. Date of Electronic Publication: 2022 May 23.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG.

Authors: Bersanelli M Giannarelli D De Giorgi U et al.

Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2020 Nov 02; Vol. 12, pp. 1758835920968463. Date of Electronic Publication: 2020 Nov 02 (Print Publication: 2020).

Publication Type: Journal Article

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

EGFR-RAD51 gene fusion NSCLC responsiveness to different generation EGFR-TKIs: two cases and review of the literature.

Authors: Di Federico A Filetti M Palladini A et al.

Source: Translational lung cancer research [Transl Lung Cancer Res] 2022 Mar; Vol. 11 (3), pp. 497-503.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101646875 Publication Model: Print Cited Medium: Print ISSN: 2218-6751 (Print) Linking ISSN: 22186751 NLM ISO Abbreviation: Transl Lung Cancer Res Subsets: PubMed not MEDLINE

The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer.

Authors: Banna GL Cortellini A Cortinovis DL et al.

Source: ESMO open [ESMO Open] 2021 Apr; Vol. 6 (2), pp. 100078. Date of Electronic Publication: 2021 Mar 16.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy.

Authors: Cortellini A Di Maio M Nigro O et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Apr; Vol. 9 (4).

Publication Type: Comparative Study; Journal Article; Multicenter Study

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Motivational intensity and visual word search: Layout matters.

Authors: Filetti M Barral O Jacucci G et al.

Source: PloS one [PLoS One] 2019 Jul 23; Vol. 14 (7), pp. e0218926. Date of Electronic Publication: 2019 Jul 23 (Print Publication: 2019).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Comparing efficacy and safety of upfront treatment strategies for anaplastic lymphoma kinase-positive non-small cell lung cancer: a network meta-analysis.

Authors: Filetti M Lombardi P Falcone R et al.

Source: Exploration of targeted anti-tumor therapy [Explor Target Antitumor Ther] 2023; Vol. 4 (6), pp. 1136-1144. Date of Electronic Publication: 2023 Dec 01.

Publication Type: Systematic Review; Journal Article

Journal Info: Publisher: Open Exploration Country of Publication: United States NLM ID: 101770662 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2692-3114 (Electronic) Linking ISSN: 26923114 NLM ISO Abbreviation: Explor Target Antitumor Ther Subsets: PubMed not MEDLINE

Latency as a region contrast: Measuring ERP latency differences with Dynamic Time Warping.

Authors: Zoumpoulaki, A. Alsufyani, A. Filetti, M. et al.

Source: Psychophysiology. Dec2015, Vol. 52 Issue 12, p1559-1576.

Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario.

Authors: Cantini L Mentrasti G Russo GL et al.

Source: ESMO open [ESMO Open] 2022 Apr; Vol. 7 (2), pp. 100406. Date of Electronic Publication: 2022 Feb 03.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.

Authors: Pinato DJ Tabernero J Bower M et al.

Corporate Authors: Pinato DJ Tabernero J Bower M et al.

Source: The Lancet. Oncology [Lancet Oncol] 2021 Dec; Vol. 22 (12), pp. 1669-1680. Date of Electronic Publication: 2021 Nov 03.

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy.

Authors: Buti S Bersanelli M Perrone F et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Jun; Vol. 150, pp. 224-231. Date of Electronic Publication: 2021 May 03.

Publication Type: Journal Article; Multicenter Study; Validation Study

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a multicenter prospective observational study (INVIDIa-2).

Authors: Bersanelli M Giannarelli D De Giorgi U et al.

Corporate Authors: Bersanelli M Giannarelli D De Giorgi U et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 May; Vol. 9 (5).

Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE